SEC Form 4 · accession 0001615774-18-000031
Zynerba Pharmaceuticals, Inc. · ZYNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rapp
10% Owner
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 6:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001621443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2018 | P | 15,000 | $12.9898 | A | 1,469,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.